Senior insider sale
See Remarks at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$26.3K
8.63K shares
What this filing means
HUNT DOUGLAS M plans to sell 8.63K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $26.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/2/2025ACC: 0001610717-25-000002
Officer· See Remarks
Since Feb 2026
8.63K
Shares to sell
$26.3K
Approx. market value
86.03K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
37.89KRestricted Stock Unit Grant
Compensation for Services Rendered
2/10/2023
48.14KTotal acquired86.03K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 37.89K | — |
2/10/2023 | Restricted Stock Unit Grant Compensation for Services Rendered | 48.14K | — |
| Total | 86.03K | ||
Planned & Completed Dispositions1
NASDAQGSPlanned
Units to sell
8.63K
Market value
$26.3K
1/2/2025
Total
Units
8.63K
Value
$26.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/2/2025 | 8.63K | $26.3K | NASDAQGS | Planned |
| Total | 8.63K | $26.3K | ||